ACT-PFK-158, 2HCl

· Advanced Cancer Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACT-PFK-158, 2HCl, covering 2015-06-23 to 2015-06-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies [Phase 1]